| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| delta-9-tetrahydrocannabinol 26 mg/mL oral oil |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 2.5 mg + cannabidiol 2.5 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 10 mg + cannabidiol 10 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| prednisolone acetate 1% eye drops |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| fluorouracil 0.5% + salicylic acid 10% solution |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| elasomeran 200 microgram/mL injection, 5 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| soya oil 15 g/1.4 L + medium chain triglycerides 15 g/1.4 L + olive oil 12 g/1.4 L + fish oil 7.4 g/1.4 L injection, 245 mL chamber |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| retinol palmitate 1500 microgram RE/0.2 mL oral liquid |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| simethicone 40 mg/mL oral liquid |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| ibuprofen 600 mg modified release tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 25 mg/mL oral oil |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 19% bud |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 15% + cannabidiol less than 1% bud |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 20 mg/mL + cannabidiol less than 3 mg/mL oral oil |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| cefuroxime 750 mg injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 55% powder |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| glucose 95 g/1.4 L injection, 805 mL chamber |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| cobicistat 150 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 20 mg/mL + cannabidiol 5 mg/mL oral oil |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol less than 1 mg/mL + cannabidiol 20 mg/mL oral oil |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
| rurioctocog alfa pegol 1500 units injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 20 mg/mL + cannabidiol less than or equal to 1 mg/mL oral oil |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol less than or equal to 1 mg/mL + cannabidiol 25 mg/mL oral oil |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 20% bud |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 12.5 mg/mL + cannabidiol 12.5 mg/mL oral oil |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| sodium glycerophosphate 4.32 g/20 mL injection, ampoule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| rurioctocog alfa pegol 3000 units injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| alanine 4.9 g/1.4 L + arginine 4.2 g/1.4 L + glycine 3.9 g/1.4 L + histidine 1.1 g/1.4 L + isoleucine 1.8 g/1.4 L + leucine 2.6 g/1.4 L + lysine 2.3 g/1.4 L + methionine 1.5 g/1.4 L + phenylalanine 1.8 g/1.4 L + proline 3.9 g/1.4 L + serine 2.3 g/1.4 L + taurine 350 mg/1.4 L + threonine 1.5 g/1.4 L + tryptophan 700 mg/1.4 L + tyrosine 140 mg/1.4 L + valine 2.2 g/1.4 L + calcium chloride 200 mg/1.4 L + sodium glycerophosphate 1.5 g/1.4 L + magnesium sulfate 420 mg/1.4 L + potassium chloride 1.6 g (potassium 21 mmol)/1.4 L + sodium acetate 1.2 g/1.4 L + zinc sulfate 4.5 mg/1.4 L injection, 350 mL chamber |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 18% bud |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| bortezomib 3.5 mg/1.4 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| bortezomib 2.5 mg/mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| esmolol hydrochloride 2.5 g injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| drospirenone 4 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| inclisiran 284 mg/1.5 mL injection, syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| arsenic trioxide 10 mg/10 mL injection, ampoule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| budesonide 500 microgram orally disintegrating tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dexmedetomidine 400 microgram/4 mL injection, ampoule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| fluorouracil 4% cream |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| hydrocortisone 100 mg injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| atropine sulfate monohydrate 0.01% eye drops, ampoule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| sodium picosulfate 10.3 mg + magnesium carbonate hydrate 7.4 g + citric acid 12.2 g powder for oral liquid, 20 g sachet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| liquid paraffin 1 g/g liquid |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
| sotrovimab 500 mg/8 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| burosumab 20 mg/mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| burosumab 30 mg/mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| burosumab 10 mg/mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| daratumumab 1.8 g/15 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| magnesium carbonate hydrate 7.2 g + citric acid 14.3 g powder for oral liquid, 21.5 g sachet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| budesonide 160 microgram/actuation + glycopyrronium 7.2 microgram/actuation + formoterol fumarate dihydrate 5 microgram/actuation inhalation, actuation |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| glycomacropeptide and essential amino acids with vitamins and minerals containing 10 g of protein equivalent powder for oral liquid, 15 g sachet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| upadacitinib 30 mg modified release tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| pholcodine 10.5 mg/7 mL + phenylephrine hydrochloride 10.5 mg/7 mL oral liquid |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| bemotrizinol 1.7% + butyl methoxydibenzoylmethane 2.5% + octocrylene 2% + octyl methoxycinnamate 6% + diethylamino hydroxybenzoyl hexyl benzoate 2% + titanium dioxide 4.2% lotion |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| Andrographis paniculata extract 178.58 mg + olive leaf extract 150 mg + purple coneflower extract 25 mg + ascorbic acid 250 mg + citrus bioflavonoids extract 50 mg + zinc 6 mg + colecalciferol 3.75 microgram (150 units) + retinol palmitate 175 microgram RE capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| colecalciferol 25 microgram (1000 units)/actuation + menaquinone-7 45 microgram/actuation oral liquid, actuation |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| almond oil 2.85% + zinc oxide 1.6% cream |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dressing foam with silicone light exudate 4 cm x 5 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dressing foam with silicone light exudate 5 cm x 12.5 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dressing foam heavy exudate 20 cm x 20 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dressing foam heavy exudate 5 cm x 5 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dressing foam heavy exudate 22.5 cm x 32.5 cm dressing |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dressing foam heavy exudate 17.5 cm x 22.5 cm dressing |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dressing foam heavy exudate 12.5 cm x 12.5 cm dressing |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dressing foam with silicone moderate exudate 5 cm x 12.5 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dressing foam with silicone moderate exudate 4 cm x 5 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| casirivimab 120 mg/mL injection, 2.5 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dressing alginate with silver cavity wound 3 cm x 44 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| imdevimab 120 mg/mL injection, 2.5 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dressing alginate with silver deep wound 5 cm x 5 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dressing alginate with silver deep wound 10 cm x 10 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dressing foam heavy exudate 10 cm x 13 cm dressing |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
| imdevimab 120 mg/mL injection, 11.1 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| casirivimab 120 mg/mL injection, 11.1 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dressing foam heavy exudate 10 cm x 23 cm dressing |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dressing foam heavy exudate 23 cm x 25 cm dressing |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
| cabazitaxel 60 mg/3 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| ivacaftor 25 mg granules, sachet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| aciclovir 1 g/40 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride 4% gel, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dry ivy leaf extract 8.45 mg/mL oral liquid |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dressing non-adherent absorbent 10 cm x 23 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| nicotine 59 mg/mL inhalation solution, cartridge |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dressing non-adherent absorbent 17.5 cm x 22.5 cm hydroactive dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dressing non-adherent absorbent 23 cm x 25 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dressing non-adherent absorbent 10 cm x 13 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dressing non-adherent absorbent 22.5 cm x 32.5 cm hydroactive dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| simethicone 240 mg/2 mL liquid |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| finerenone 10 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| finerenone 20 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| vericiguat 2.5 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| natalizumab 150 mg/mL injection, syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| vericiguat 10 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| vericiguat 5 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dolutegravir 5 mg dispersible tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| calcium gluconate monohydrate 931 mg/10 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| tezacaftor 50 mg + ivacaftor 75 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| thiamine 50 mg + riboflavin 20 mg + nicotinamide 50 mg + pantothenic acid 100 mg + pyridoxine 30 mg + folinic acid 200 microgram + levomefolic acid 200 microgram + mecobalamin 200 microgram + hydroxocobalamin 200 microgram + biotin 300 microgram + choline 100 mg + inositol 100 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| ivacaftor 75 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| tozinameran injection, 1.3 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| tozinameran 30 microgram/0.3 mL injection, 2.25 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| turmeric extract 200 mg + devil's claw extract 100 mg + Indian frankincense extract 125 mg + white willow extract 120 mg + black pepper extract 1.58 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|